Food Allergy Clinical Trial
— BAT2Official title:
Basophil Activation Test to Diagnose Food Allergy
NCT number | NCT03309488 |
Other study ID # | IRAS 197886 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | January 30, 2018 |
Est. completion date | July 31, 2021 |
The BAT II Study is a cross-sectional diagnostic study in which children with suspected IgE-mediated allergy to foods (namely cow's milk, egg, sesame and cashew), as defined by a history of an immediate-type allergic reaction to a food or no history of food consumption or the presence of food-specific IgE as documented by skin prick test or serum specific IgE, will undergo a diagnostic work-up to confirm or refute the diagnosis of IgE-mediated food allergy. Participants will be prospectively recruited from specialised Paediatric Allergy clinics in London and will undergo skin prick testing (SPT), specific IgE testing to allergen extracts and allergen components, basophil activation test (BAT) and oral food challenge. The diagnostic accuracy of the BAT and of other allergy tests will be assessed against the clinical gold-standard.
Status | Recruiting |
Enrollment | 600 |
Est. completion date | July 31, 2021 |
Est. primary completion date | July 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Months to 16 Years |
Eligibility |
Inclusion Criteria: 1. Children =6 months and <16 years old; 2. Suspected IgE-mediated food allergy defined by: - History of an immediate-type allergic reaction to a specific food or - No history of consumption of the specific food or - IgE sensitisation documented by skin prick test (=1 mm) or serum specific IgE (=0.10 KU/L); 3. Avoidance of the specific food for at least 2 days prior to blood collection for BAT and specific IgE and prior to the challenge; 4. Informed consent obtained from parent or guardian and assent obtained from the child. Exclusion Criteria: 1. Clinically significant chronic illness other than atopic diseases; 2. Previous history of severe life-threatening reaction to the suspected food with documented decrease in oxygen saturation (<90%), hypotension (=20% reduction in systolic blood pressure) and/or admission to intensive care; 3. Unwillingness to comply with study procedures, namely to undergo a diagnostic food challenge; 4. Contra-indication for diagnostic food challenge, namely: - Uncontrolled atopic diseases (e.g. eczema, asthma, rhinitis); - Chronic medical conditions that pose significant risk in the event of anaphylaxis or treatment of anaphylaxis (e.g. cardiac disease, severe lung disease, pregnancy, mastocytosis); - Inability to discontinue medications that might interfere with assessment or safety (e.g. antihistamines, ß-agonists, ß-blockers, NSAIDs, ACE inhibitor, antacids); - Recent (within 7-14 days) treatment with systemic steroids or prolonged high-dose systemic steroids or immunosuppressants; 5. Undergoing treatment with omalizumab, food allergen immunotherapy or other systemic immunomodulatory treatment; 6. Inability to stop anti-histamines prior to SPT. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Pediatric Allergy Clinical Research Facility, Evelina Children's Hospital | London |
Lead Sponsor | Collaborator |
---|---|
King's College London | Guy's and St Thomas' NHS Foundation Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Diagnostic accuracy of the basophil activation test (for each individual food allergy) | Accuracy of %CD63+ basophils | 3 years | |
Secondary | Diagnostic accuracy of SPT, specific IgE to extracts and to single allergens | Accuracy of weal diameter or level of IgE | 3 years | |
Secondary | Association between BAT and severity of symptoms during challenges | Correlation between %CD63+ basophils and severity grade | 3 years | |
Secondary | Association between BAT and threshold of reactivity during challenges | Correlation between CD-sens and cumulative threshold dose | 3 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03089476 -
Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy
|
N/A | |
Recruiting |
NCT05839405 -
Food Allergy in the Brain
|
||
Completed |
NCT02552537 -
iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions
|
Phase 4 | |
Completed |
NCT01634737 -
Crustacean Allergy and Dust Mites Sensitization
|
N/A | |
Recruiting |
NCT05521711 -
TRADE Trial - Tree Nut Immunotherapy Route Development and Evaluation
|
N/A | |
Completed |
NCT05072665 -
Fast Allergy Sensitivity Test
|
N/A | |
Active, not recruiting |
NCT04887441 -
Allergology: Information, Data and Knowledge Organization
|
||
Recruiting |
NCT03265262 -
The Basophil Activation Test as a Diagnostic Tool in Pediatric Food Allergy
|
N/A | |
Completed |
NCT04186949 -
Early Origins of Allergy and Asthma
|
||
Completed |
NCT02490007 -
Pertussis Immunisation and Food Allergy
|
||
Recruiting |
NCT03151252 -
Improvement of Foodallergy Diagnostic in Gastrointestinal Tract
|
N/A | |
Completed |
NCT02159833 -
Intranasal Diagnostics in Food Allergy: a Feasibility Study
|
N/A | |
Completed |
NCT02377284 -
Prevention and Management of Food Allergies
|
N/A | |
Completed |
NCT02354729 -
Encouraging Allergic Young Adults to Carry Epinephrine
|
N/A | |
Completed |
NCT02640560 -
One-year Survey of Anaphylaxis in Outpatient Children Allergic to Peanuts, Walnuts/Hazelnuts, Shellfish
|
N/A | |
Enrolling by invitation |
NCT06097572 -
Improved Diagnostics in Food Allergy Study
|
N/A | |
Recruiting |
NCT04606615 -
Skin Barrier Abnormalities and Oxidative Stress Response
|
||
Recruiting |
NCT05785299 -
Clinical Versus Home Introduction of Milk in Children With Non-IgE-mediated Cow's Milk Allergy
|
N/A | |
Not yet recruiting |
NCT06112873 -
Quality of Life in Food Allergy: Validation of Three Mini-questionnaires
|
||
Completed |
NCT03337802 -
Effect of Mediterranean Diet During Pregnancy on the Onset of Overweight and Obesity in the Offspring
|
N/A |